Skip to main content
Log in

Clinical association between thyroid disease and immune thrombocytopenia

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Immune thrombocytopenia (ITP) can coexist with autoimmune thyroid disease. However, the detailed clinical features remain unknown. We retrospectively reviewed 248 patients with newly diagnosed ITP in our institute for whom we had thyroid function data at diagnosis between 2000 and 2019. Of the 248 patients with ITP, 74 patients also had thyroid disease, including 36 with overt thyroid disease (13 Graves’ disease and 23 Hashimoto’s thyroiditis) and 38 with subclinical thyroid disease (3 hyperthyroidism and 35 hypothyroidism). ITP and thyroid disease were concurrently diagnosed in 54 patients. Female sex and positivity for antinuclear antibodies (ANA) were significantly associated with thyroid diseases. Platelet-associated immunoglobulin G (PAIgG) levels in patients with Graves’ disease were higher than those in patients with Hashimoto’s thyroiditis. Platelet counts were similar among euthyroid patients and patients with thyroid disease. Thrombopoietin-receptor agonist was administered more frequently in patients with thyroid disease. The cumulative incidences of thrombosis and bleeding and overall survival did not differ between patients with and without thyroid disease. Treatment for thyroid disease in 22 patients improved thrombocytopenia in 21 patients, especially in 4 patients who were not treated for ITP. This study demonstrated that thyroid diseases were commonly found in patients with ITP. Treatment of the underlying thyroid disease may improve thrombocytopenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nugent D, McMillan R, Nichol JL, Slichter SJ (2009) Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 146(6):585–596. https://doi.org/10.1111/j.1365-2141.2009.07717.x

    Article  CAS  PubMed  Google Scholar 

  2. Crabtree GR, Lee JC, Cornwell GG 3rd (1975) Letter: Autoimmune thrombocytopenia purpura and Hashimoto’s thyroiditis. Ann Intern Med 83(3):371–372. https://doi.org/10.7326/0003-4819-83-3-371

    Article  CAS  PubMed  Google Scholar 

  3. Jacobs P, Majoos F, Perrotta A (1984) Hyperthyroidism and immune thrombocytopenia. Postgrad Med J 60(708):657–661. https://doi.org/10.1136/pgmj.60.708.657

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Pavithran K, Sreekumar A, Krishnamohan VE (1996) Idiopathic thrombocytopenic purpura associated with Graves’ disease-case report. Indian J Med Sci 50(2):43–46

    CAS  PubMed  Google Scholar 

  5. Cordiano I, Betterle C, Spadaccino CA, Soini B, Girolami A, Fabris F (1998) Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol 113(3):373–378. https://doi.org/10.1046/j.1365-2249.1998.00677.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ioachimescu AG, Makdissi A, Lichtin A, Zimmerman RS (2007) Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study. Thyroid 17(11):1137–1142. https://doi.org/10.1089/thy.2007.0066

    Article  PubMed  Google Scholar 

  7. Kohli RS, Bleibel W, Bleibel H (2007) Concurrent immune thrombocytopenic purpura and Guillain-Barre syndrome in a patient with Hashimoto’s thyroiditis. Am J Hematol 82(4):307–308. https://doi.org/10.1002/ajh.20771

    Article  PubMed  Google Scholar 

  8. Liebman H (2007) Other immune thrombocytopenias. Semin Hematol 44(4 Suppl 5):S24–S34. https://doi.org/10.1053/j.seminhematol.2007.11.004

    Article  PubMed  Google Scholar 

  9. Dogan M, Sal E, Akbayram S, Peker E, Cesur Y, Oner AF (2011) Concurrent celiac disease, idiopathic thrombocytopenic purpura and autoimmune thyroiditis: a case report. Clin Appl Thromb Hemost 17(6):E13–E16. https://doi.org/10.1177/1076029610378502

    Article  PubMed  Google Scholar 

  10. Beyan C, Kaptan K (2013) Reactive thrombocytosis accompanying subclinical hypothyroidism due to Hashimoto’s thyroiditis. Blood Coagul Fibrinolysis 24(6):649–651. https://doi.org/10.1097/MBC.0b013e32836069f5

    Article  PubMed  Google Scholar 

  11. Marta GN, de Campos FP (2015) Immune thrombocytopenia and autoimmune thyroid disease: a controversial overlap. Autops Case Rep 5(2):45–48. https://doi.org/10.4322/acr.2015.002

    Article  PubMed  PubMed Central  Google Scholar 

  12. Tahir H, Sheraz F, Sagi J, Daruwalla V (2016) Immune thrombocytopenia (ITP) secondary to subclinical Hashimoto’s thyroiditis: role of levothyroxine in improving the clinical outcome of ITP. J Investig Med High Impact Case Rep 4(2):2324709616647085. https://doi.org/10.1177/2324709616647085

    Article  PubMed  PubMed Central  Google Scholar 

  13. Shekhda KM (2018) The association of hyperthyroidism and immune thrombocytopenia: are we still missing something? Tzu Chi Med J 30(3):188–190. https://doi.org/10.4103/tcmj.tcmj_139_17

    Article  PubMed Central  Google Scholar 

  14. Fonseca S, Lacerda C, Ganhao I, Castro S (2019) Thrombocytopaenia and thyroiditis: coincidence? BMJ Case Rep 12(7):e228411. https://doi.org/10.1136/bcr-2018-228411

    Article  PubMed  Google Scholar 

  15. Hofbauer LC, Spitzweg C, Schmauss S, Heufelder AE (1997) Graves disease associated with autoimmune thrombocytopenic purpura. Arch Intern Med 157(9):1033–1036

    Article  CAS  Google Scholar 

  16. Bowles KM, Turner GE, Wimperis JZ (2004) Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism. J Clin Pathol 57(9):995–996. https://doi.org/10.1136/jcp.2004.016543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Sugimoto K, Sasaki M, Isobe Y, Tamayose K, Hieda M, Oshimi K (2005) Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy. Eur J Haematol 74(1):73–74. https://doi.org/10.1111/j.1600-0609.2004.00341.x

    Article  PubMed  Google Scholar 

  18. Gill H, Hwang YY, Tse E (2011) Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves’ disease. Ann Hematol 90(2):223–224. https://doi.org/10.1007/s00277-010-0983-4

    Article  PubMed  Google Scholar 

  19. Jung RS, Parghane RV, Sood A, Bhattacharya A, Mittal BR (2014) Primary autoimmune thrombocytopenia and co-existing Graves’ disease: role of radioiodine-131. Indian J Nucl Med 29(3):195–196. https://doi.org/10.4103/0972-3919.136602

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hollenhorst MA, Al-Samkari H, Kuter DJ (2019) Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance. Blood Adv 3(22):3515–3521. https://doi.org/10.1182/bloodadvances.2019000400

    Article  PubMed  PubMed Central  Google Scholar 

  21. Giordano P, Urbano F, Lassandro G, Bianchi FP, Tolva A, Saracco P, Russo G, Notarangelo LD, Gabelli M, Cesaro S, Wasniewska M, Faienza MF (2019) Role of antithyroid autoimmunity as a predictive biomarker of chronic immune thrombocytopenia. Pediatr Blood Cancer 66(1):e27452. https://doi.org/10.1002/pbc.27452

    Article  CAS  PubMed  Google Scholar 

  22. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386–2393. https://doi.org/10.1182/blood-2008-07-162503

    Article  CAS  Google Scholar 

  23. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190–4207. https://doi.org/10.1182/blood-2010-08-302984

    Article  CAS  PubMed  Google Scholar 

  24. Smith TJ, Hegedüs L (2016) Graves’ disease. N Engl J Med 375(16):1552–1565. https://doi.org/10.1056/NEJMra1510030

    Article  PubMed  Google Scholar 

  25. Caturegli P, De Remigis A, Rose NR (2014) Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 13(4–5):391–397. https://doi.org/10.1016/j.autrev.2014.01.007

    Article  CAS  PubMed  Google Scholar 

  26. Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48(3):452–458. https://doi.org/10.1038/bmt.2012.244

    Article  CAS  PubMed  Google Scholar 

  27. Kasagi K, Takahashi N, Inoue G, Honda T, Kawachi Y, Izumi Y (2009) Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid 19(9):937–944. https://doi.org/10.1089/thy.2009.0205

    Article  CAS  PubMed  Google Scholar 

  28. Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, Galofre JC (2014) The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 99(3):923–931. https://doi.org/10.1210/jc.2013-2409

    Article  CAS  PubMed  Google Scholar 

  29. Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ (2018) Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid 28(9):1101–1110. https://doi.org/10.1089/thy.2017.0414

    Article  PubMed  Google Scholar 

  30. Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379(9821):1142–1154. https://doi.org/10.1016/s0140-6736(11)60276-6

    Article  PubMed  Google Scholar 

  31. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2(4):215–228. https://doi.org/10.1159/000356507

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA (2012) Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 22(12):1200–1235. https://doi.org/10.1089/thy.2012.0205

    Article  CAS  PubMed  Google Scholar 

  33. Doobaree IU, Nandigam R, Bennett D, Newland A, Provan D (2016) Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis. Eur J Haematol 97(4):321–330. https://doi.org/10.1111/ejh.12777

    Article  PubMed  Google Scholar 

  34. Ito S, Fujiwara SI, Ikeda T, Toda Y, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Yamamoto C, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y (2020) Evaluation of thrombotic events in patients with immune thrombocytopenia. Ann Hematol 99(1):49–55. https://doi.org/10.1007/s00277-019-03886-6

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

SI performed the research and collected and analyzed the data. SI, SF, and YK analyzed the data and wrote the paper. All the authors wrote the paper and approved the final version.

Corresponding author

Correspondence to Yoshinobu Kanda.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this retrospective study, formal informed consent is not required. This study was approved by the Institutional Review Board of Jichi Medical University and performed in accordance with the Declaration of Helsinki and its later amendments.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(XLSX 11 kb).

ESM 2

(XLSX 11 kb).

ESM 3

(XLSX 11 kb).

ESM 4

Chronic ITP was diagnosed in a 29-year-old woman. After 6 months, she was incidentally diagnosed with Hashimoto’s thyroiditis at another hospital. She was administrated levothyroxine. Several months later, her platelet count increased to 140 × 109/l without treatment of ITP. (PPT 156 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, S., Fujiwara, Si., Murahashi, R. et al. Clinical association between thyroid disease and immune thrombocytopenia. Ann Hematol 100, 345–352 (2021). https://doi.org/10.1007/s00277-020-04343-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04343-5

Keywords

Navigation